The blood test developer took in $165m through a series B round led by SoftBank Vision Fund 2 that came three years after a Tencent-backed series A.

Manufacturing partner WuXi Biologics participated in a series A round for the startup, which aims to transfer human biopharmaceutical practices to animal drug development.

The GoHealth-backed health insurance engagement platform has now raised $53m altogether, with Health Velocity Capital leading its series C round.

Oncology therapy developer Revolution Medicines went public giving an exit to pharmaceutical company Sanofi.

The Globis-backed startup accelerator has chosen 12 participating startups for its sophomore cohort, three months after the demo day for the initial batch.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Healthcare staff management platform IntelyCare attracted Kaiser Permanente Ventures as a new investor in a series B round that increased its overall funding to $59m.

MRM Technologies has spun off inflammatory bowel disease drug developer MRM Health with $15m from investors including strategic partner DuPont.

Proceeds from the Novo-backed series B round will be used to advance Spruce Biosciences' congenital adrenal hyperplasia candidate into phase 2 trials.

WuXi AppTec has co-led a $98m series D round for China-focused drug developer Canbridge Pharmaceuticals that also featured fellow corporate Tigermed.